Contracts and intellectual property rights in translational R&D

Publication details

Mark Anderson, Naomi Hawkins and Alison Slade, 'Contracts and intellectual property rights in translational R&D: furthering safeguards in the public interest' (2024) 42 Nature Biotechnolgy 179. 

Abstract

Intellectual property safeguards should be more widely incorporated into the bilateral contracts that underpin the translational R&D process to preserve the public interest, especially where public funds and resources have spearheaded the innovation process.